Sopharma Trading AD Past Earnings Performance
Past criteria checks 3/6
Sopharma Trading AD has been growing earnings at an average annual rate of 6.5%, while the Healthcare industry saw earnings growing at 15.3% annually. Revenues have been growing at an average rate of 15.2% per year. Sopharma Trading AD's return on equity is 14.1%, and it has net margins of 1%.
Key information
6.5%
Earnings growth rate
5.2%
EPS growth rate
Healthcare Industry Growth | 15.7% |
Revenue growth rate | 15.2% |
Return on equity | 14.1% |
Net Margin | 1.0% |
Last Earnings Update | 31 Mar 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Sopharma Trading AD makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 22 | 1,378 | 13 | 99 | 0 |
31 Dec 21 | 1,336 | 8 | 98 | 0 |
30 Sep 21 | 1,333 | 15 | 97 | 0 |
30 Jun 21 | 1,269 | 13 | 88 | 0 |
31 Mar 21 | 1,190 | 12 | 79 | 0 |
31 Dec 20 | 1,156 | 11 | 72 | 0 |
30 Sep 20 | 1,068 | 10 | 64 | 0 |
30 Jun 20 | 1,017 | 10 | 64 | 0 |
31 Mar 20 | 1,002 | 11 | 65 | 0 |
31 Dec 19 | 946 | 9 | 63 | 0 |
30 Sep 19 | 929 | 8 | 62 | 0 |
30 Jun 19 | 916 | 9 | 61 | 0 |
31 Mar 19 | 901 | 9 | 61 | 0 |
31 Dec 18 | 888 | 9 | 61 | 0 |
30 Sep 18 | 866 | 8 | 61 | 0 |
30 Jun 18 | 825 | 8 | 60 | 0 |
31 Mar 18 | 776 | 8 | 57 | 0 |
31 Dec 17 | 721 | 9 | 54 | 0 |
30 Sep 17 | 669 | 10 | 50 | 0 |
30 Jun 17 | 642 | 10 | 46 | 0 |
31 Mar 17 | 626 | 11 | 45 | 0 |
31 Dec 16 | 613 | 11 | 42 | 0 |
30 Sep 16 | 602 | 10 | 41 | 0 |
30 Jun 16 | 604 | 11 | 40 | 0 |
31 Mar 16 | 603 | 11 | 39 | 0 |
31 Dec 15 | 603 | 11 | 38 | 0 |
30 Sep 15 | 598 | 12 | 37 | 0 |
Quality Earnings: 6YH has a high level of non-cash earnings.
Growing Profit Margin: 6YH's current net profit margins (1%) are lower than last year (1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6YH's earnings have grown by 6.5% per year over the past 5 years.
Accelerating Growth: 6YH's earnings growth over the past year (12.2%) exceeds its 5-year average (6.5% per year).
Earnings vs Industry: 6YH earnings growth over the past year (12.2%) exceeded the Healthcare industry -16.1%.
Return on Equity
High ROE: 6YH's Return on Equity (14.1%) is considered low.